CHRNB1 IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with CHRNB1 IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with CHRNB1 IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with CHRNB1 IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CHRNB1 IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

dual specificity phosphatase 13A

Gene

long intergenic non-protein coding RNA 2898

Gene

adhesion G protein-coupled receptor F5 pseudogene 1

Gene

ribosomal protein L7 pseudogene 3

Gene

BCL2 interacting protein 3 pseudogene 28

Gene

spermatogenesis associated 2 pseudogene 1

Gene

transportin 1 pseudogene 2

Gene

chloride voltage-gated channel 1

Gene

myomesin 1

Gene

ADP-ribosylhydrolase like 1

  • Gene

    dual specificity phosphatase 13A


  • Gene

    long intergenic non-protein coding RNA 2898


  • Gene

    adhesion G protein-coupled receptor F5 pseudogene 1


  • Gene

    ribosomal protein L7 pseudogene 3


  • Gene

    BCL2 interacting protein 3 pseudogene 28


  • Gene

    spermatogenesis associated 2 pseudogene 1


  • Gene

    transportin 1 pseudogene 2


  • Gene

    chloride voltage-gated channel 1



  • Gene

    ADP-ribosylhydrolase like 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.